Caspase-3 Regulatory Mechanisms

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 65: Line 65:
Aside from phosphorylation, caspase-3 is also known to be ubiquitinylated and nitrosylated, however the underlying mechanismsand effect of these modifications are still unclear.
Aside from phosphorylation, caspase-3 is also known to be ubiquitinylated and nitrosylated, however the underlying mechanismsand effect of these modifications are still unclear.
-
==== Natural Inhibitors====
+
=== Natural Inhibitors===
<scene name='Caspase-3_Regulatory_Mechanisms/Bir2/1'>Casp3 bound to BIR2 domain</scene>
<scene name='Caspase-3_Regulatory_Mechanisms/Bir2/1'>Casp3 bound to BIR2 domain</scene>
X-linked inhibitor of apoptosis proteins (XIAP) contains the second baculovirus IAP repeat domain (BIR2) targeting caspase-3 and caspase-7. The <scene name='Caspase-3_Regulatory_Mechanisms/Bir2/2'>BIR2</scene> domain sits directly in the active site of caspase-3 and completely inhibits the protein. The region binding the active site runs in the opposite direction of normal caspase-3 substrates, thus occupying P1 through P4 but avoiding cleavage by the protease. This unique method of inhibition is a critical regulatory mechanism used in cells to control apoptotic caspase activity.
X-linked inhibitor of apoptosis proteins (XIAP) contains the second baculovirus IAP repeat domain (BIR2) targeting caspase-3 and caspase-7. The <scene name='Caspase-3_Regulatory_Mechanisms/Bir2/2'>BIR2</scene> domain sits directly in the active site of caspase-3 and completely inhibits the protein. The region binding the active site runs in the opposite direction of normal caspase-3 substrates, thus occupying P1 through P4 but avoiding cleavage by the protease. This unique method of inhibition is a critical regulatory mechanism used in cells to control apoptotic caspase activity.
-
=Reference=
+
=References=
Bose, K., C. Pop, et al. (2003). "An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3." Biochemistry 42(42): 12298-12310.
Bose, K., C. Pop, et al. (2003). "An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3." Biochemistry 42(42): 12298-12310.

Revision as of 03:48, 13 December 2012

Contents

Introduction

Caspases in the apoptotic pathway
Caspases in the apoptotic pathway

Caspases are cysteine-aspartic acid proteases and are key protein facilitators for the faithful execution of apoptosis or programmed cell death. Dysregulation in the apoptotic pathway has been implicated in a variety of diseases such as neurodegeneration, cancer, heart disease and some metabolic disorders. Because of the crucial role of caspases in the the apoptotic pathway, abnormalities in their functions would cause a haywire in the apoptotic cascade and can be deleterious to the cell. Caspases are thus being considered as therapeutic targets in apoptosis-related diseases.

Any apoptotic signal received by the cell causes the activation of initiator caspases (-8 and -9) by associating with other protein platforms to form a functional holoenzyme. These initiator caspases then cleaves the executioner caspases -3, -6, -7. Caspase-3 specifically functions to cleave both caspase-6 and -7, which in turn cleave their respective targets to induce cell death. Aside from being able to activate caspase-6 and -7, caspase-3 also regulates caspase-9 activity, operating via a feedback loop. This dual action of caspase-3 confers its distinct regulatory mechanisms, resulting a wider extent of its effects in the apoptotic cascade.


Overview of Caspase-3 Structure

Caspase-3 (PDB entry 2h5i)

Drag the structure with the mouse to rotate

Caspase-3 Loop Bundle and Active Site

Structure of Caspase-3 (PDB entry 2H5I)

Drag the structure with the mouse to rotate

Caspase-3 Regulation

Structure of Caspase-3 with BIR2 domain (PDB entry 1I3O)

Drag the structure with the mouse to rotate
Personal tools